In order to investigate the proliferative and apoptotic effects of phloretin on human hepatoma cell line SMMC-7721 and to explore the mechanisms of phloretin induced apoptosis, this research is set to observed morphological alterations with phase contrast and confocal microscopy, performed MTT assay, and detected apoptotic rates, cell cycle progression, mitochondrial trans-membrane potential and intracellular calcium homeostasis. The results suggested that typical apoptotic morphological alterations occurred after phloretin treatment. Phloretin exerts a strong inhibitory on the proliferation of SMMC-7721 cell line, and induces its apoptosis in a dosage and duration dependent manner. Cell cycle was arrested at G1 phase. Mitochondrial trans-membrane potential dropped. Calcium homeostasis was disturbed. It is concluded that phloretin can induce apoptosis of SMMC-7721 via arresting cell cycle progression, reducing mitochondrial trans-membrane potential and disturbing intracellular calcium homeostasis.
INTRODUCTION
One of the most important mechanisms underlying tumorigenesis is uncontrolled proliferation and apoptosis. Consequently, the crux of tumor therapy is to inhibit cell division and induce apoptosis. Apoptosis occurs through activation of a cell suicide process regulated by many different intracellular and extracellular events. Apoptosis is governed by several genes, some of which are mutated or dysfunctionally regulated in various types of human tumors (Brown and Attardi, 2005) . Apoptosis, as programmed cell death, is the most well-defined type of cell death pathway, both morphologically and biochemically. It is characterized by membrane blebbing, cytoplasmic shrinkage and reduction of cellular volume (pyknosis), condensation of the chromatin, and *Corresponding author. weijunguan301@gmail.com. #These authors contributed equally to this article. fragmentation of the nucleus (karyorrhexis), all of which ultimately lead to formation of apoptotic bodies, a prominent morphological feature of apoptotic cell death (Kroemer et al., 2005) .
Induced apoptosis of tumor cells provides a new strategy and was believed to hold profound significance for prevention and cure of neoplastic transformation. Cancer is a prevailing lethal pathology, and commonly used therapies of hepatoma can hardly achieve satisfactory results. Traditional Chinese medicine, the essence accumulated throughout centuries, attracts more and more attention owing to its remarkable curative effects on cancer. Drug induced apoptosis of malignant cells is presumably a promising tumor therapeutic strategy and emerging evidence is supporting its effectiveness against hepatoma as well as other cancers.
Phloretin, a natural active compound, belongs to flavonoids, exists in sap of apple, pear and other fruits and vegetables. Phloretin has been studied as a possible penetration enhancer for skin-based drug delivery (Auner et al., 2003) , attenuates inflammation by antagonizing prostaglandins (Blazso and Gabor, 1995) , protects the skin from UV light-induced photodamage (Oresajo, 2008) , and is currently evaluated as a chemopreventive agent for cancer treatment. It can serve the purposes of anti-oxidation, antitumor, anti-diabetes, antibiosis and para-hormone under physiological context (Chih-Hsiung, 2009; He, 2007; Yoon and Liu, 2007) . Besides its potent antioxidant property, phloretin is known to be a competitive inhibitor of sodium D-glucose cotransporter (Raja et al., 2003) . Phloretin exert anti-inflammatory effect through suppressing macrophage function.
Phloretin, because of its effects on cell proliferation disorders, is one promising anti-mutagenic factors that can be used for hepatoma treatment and other tumors, and thus is a potential chemotherapeutic agent. There are 4 hydroxyls (-OH) in its chemical structure, which can well inhibit the trans-membrane transport of saccharide, leading to apoptosis of malignant cells (Figure 1) . In many studies, phloretin was showed to induce apoptosis of tumor cells via diverse path ways, such as inhibition of glucose transportation, stimulation of estrogen receptor or mitochondrial pathways (Blobel and Orkin, 1996) , and it has long been known as non-specific PKC inhibitor (Gschwendt et al., 1984) , can inhibit cell proliferation and induce apoptosis via PKC pathway (Jarvis et al., 1994) .Phloretin also inhibits the growth of bladder cancer and rat mammary adenocarcinoma cells in vivo (Nelson and Falk, 1993) .
In elucidating the therapeutic values of phloretin, this research investigated its apoptotic effects and mechanism on human hepatoma cells.
MATERIALS AND METHODS
Human hepatoma cells SMMC-7721 was purchased from Peking Union Medical College. Phloretin was purchased from Sigma Inc. Dulbecco"s modified Eagle"s medium (DMEM) and fetal bovine serum (FBS) was purchased from Gibco. Annexin V-FITC Apoptosis Detection Kit I was purchased from BD corporation.
Cell culture
The cells were cultured in DMEM medium containing 10% FBS in a Wang et al. 649 37°C incubator with 5% CO2 (Guan, 2005; Zhou, et al 2004) . The medium was refreshed when it became yellow. Cells were dissociated when they reached 80 to 90% confluence and were sub-cultured into sterilized flasks at the ratio of 1:2 or 1:3.
Growth dynamics
Following the method of Gu et al. (2006) and Kong et al. (2007) , cells at the concentration of 2.0×10 4 cells/ ml were plated into 24-well micro plates. Data on cell growth and density were calculated and recorded each day until plateau phase; three wells were counted each time. The growth curve was then plotted and the population doubling time (PDT) was calculated according to this curve.
Drug solution preparation and treatment
Phloretin was dissolved with Dimethyl sulfoxide (DMSO), diluted with DMEM medium, filtered for sterilization, aliquoted.
It should be diluted to the required concentration with DMEM medium prior to treatment, and the final concentration of DMSO should be 0.05% in experiments, for control specimens, the same volume of 0.05% DMSO without phloretin was added. The experimental cells were logarithmic phase. After treatment with DMEM medium containing phloretin or DMSO, they were cultured to the scheduled time.
Morphological observation
Observation by inverted phase contrast microscope 2 ml suspension was plated on each well of 6-well micro plates at the concentration of 2.0×10 5 cells/well. Cells in logarithmic phase were treated with phloretin-containing complete DMEM medium for 24 h. Morphological alterations were observed and photographed using inverted phase contrast microscope.
Fluorescent observation using confocal microscopy
To visualize the morphological alterations of apoptotic nuclei, acridine orange (AO) and ethidium bromide (EB) fluorescent staining of phloretin treated cells was performed. Cells were treated by phloretin for 24 h. Cell suspension was harvested from each well, and stained with AO, EB solution (both 2 mg/ml in ethanol) of 6 µl, and gently mixed. Incubated at room temperature in the dark for 5 min, the samples were then observed using confocal microscopy (Nikon TE-2000-E, Japan) immediately.
Observation by transmission electron microscopy
The cells of controls and experimental samples were collected, and fixed with 2.5% (m/v) glutaraldehyde, then washed with 0.1 mol/L phosphate buffered and subjected to serial dehydration with 30, 50, 70, 80, 90 and 100% acetone (v/v) . The samples were embedded with epoxy resin (SPURR) for polymerization, then slice thin slices with ultramicrotome (LEICAUC6i), Uranyl acetate and lead citrate for double staining. The samples were observed using transmission electron microscopy (JEM-123O).
MTT colorimetric assay
The 3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to evaluate cytotoxicity as described by Ho et al. (2005) . Cell suspension of 200 μl was placed on each well of 96-well micro plates at the concentration of 1.0×10 5 cells/well. Cells in logarithmic growth phase, with phloretin containing complete DMEM media and corresponding controls were set simultaneously. 6 replicates were prepared for each treatment and cultured until 12, 24, 36 and 48 h. After the addition of MTT 20 μl (5 mg/ml phosphate buffered saline (PBS)) each well, the cells were cultured for another 4 h. The supernatant was discarded. After the addition of 200 μl DMSO in each well, the samples were incubated in the dark for 30 min, and then swirled for mixing. Absorbance A at 490 nm was measured using enzymatic reader. Experiments were repeated three times.
Annexin V-FITC/PI double-labeling
The detection of apoptosis using annexin V-FITC/propidium iodide (PI) staining was performed as described previously (Cetindere et al., 2010) . The cells of controls and experimental samples were collected and adjusted to the concentration of (1-5)×10
5 cells/ml in binding buffer. For each sample, 100 μl cell suspensions was stained with 5 μl fluorescein isothiocyanate (FITC) and 5 μl PI and incubated at room temperature in the dark for 25 to 30 min. After the addition of 400 μl binding buffer each sample, and then detected with flow cytometer (FCM) (BD FACSCalibur, USA) within 1 h.
Cell cycle progression
The cell cycle stages were measured by FCM as previously described (Ho et al., 2005) . The cells of controls and experimental samples were collected and adjusted to the concentration of 1.0×10 6 cells/ml, and then spun at 1200 g, 4°C for 10 min. With supernatant discarded, they were washed twice with pre-cooling of PBS, re-suspended in ice-cold 70% ethanol (v/v), and kept at 4°C overnight. Pelleted and washed twice with PBS, the samples were stained with PI solution (PI 0.05 mg/ml, RNase 0.02 mg/ml, NaCl 0.585 g/ml, sodium citrate 1 mg/ml, pH 7.2-7.6) at 4°C for 30 min in the dark, and then detected with FCM (BD FACSCalibur, USA) immediately.
Mitochondrial transmembrane potential
Mitochondrial trans-membrane potential was determined as described previously (Yang et al, 2006; Zhang et al., 2006) . The cells of controls and experimental samples were collected and adjusted to the concentration of 1.0×10 6 cells/ml, and then spun at 1200 g, 4°C for 10 min. With supernatant discarded, they were washed twice with pre-warmed PBS. After the addition of JC-1 working solution (5 µg/ml, 0.5 ml/sample), the cells were incubated at 37°C in the dark for 10 to 15 min, and then were washed twice with pre-warmed PBS. After centrifugation at 1200 g, 4°C for 10 min, the supernatant was discarded. Each sample was resuspended with 0.5 ml PBS, and then detected with FCM (BD FACSCalibur, USA) immediately.
Intracellular calcium homeostasis
The intracellular Ca 2+ release was assessed by staining with Ca 2+ -sensitive dye Fluo3-AM (Adachi, 2008) . The cells of controls and experimental samples were collected and adjusted to the concentration of (1-2)×10 6 cells/ml. Fluo-3/Am (Invitrogen, USA) was added to each sample to reach a final concentration of 5-10 µmol/L. Incubated at 37°C, 5% CO2 in the dark for 30 to 60 min, the samples were oscillated several times gently. Prepare negative controls (without Fluo-3/Am) for reference. The cells were centrifuged at 1200 g, 4°C for 5 min, and washed twice with calcium-free PBS buffer, in order to remove the excessive dye. Each sample was resuspended in 0.5 ml calcium-free PBS, and then detected with FCM (BD FACSCalibur, USA) immediately.
Statistical analysis
Cytotoxicity data, apoptotic rates and cell cycle data were analyzed using the GLM procedure in Statistical Analysis System (SAS Inc., Cary, NC, USA) and compared with a multiple comparison test (DUNCAN). A value of P<0.05 and P<0.01 was thought of as statistically significant.
RESULTS

Growth dynamics
The growth curve of SMMC-7721 cells displayed an obvious "S" shape, and the PDT was proximately 24 h. The cells were in the latent phase in days 1 and 2, and then entered logarithmic phase in days 2 to 5. The concentration reached its peak on day 5. and then the cells entered the plateau phase in day 6, followed by an overall degeneration thenceforth (Figure 2 ).
Morphological observation
Observation using inverted phase contrast microscope Under normal circumstances, the adherent cells were elliptical shaped. In logarithmic phase, the passage cells will gradually adhere and grow. The cells of the control showed that cells were closely arranged with uniform size, as well as good vitality and refractivity ( Figure 3A) . The phloretin treated cells displayed atrophy and vacuoles ( Figure 3B ), shrinkage, cell number decrease, and cell fragmentation took place ( Figure 3C) , with blurred contour, the declined in cells connection, and even lysed into small pieces. Apoptotic cells detached from adjacent normal cells, and are obviously different in morphology ( Figure 3D and E). A typical morphological feature observed during apoptosis is the reduction of cellular volume, a feature that distinguishes this form of cell death from necrosis.
Observation using confocal microscopy
AO and EB differ in permeability and fluorescence, distinguishing cells in early apoptosis and late apoptosis. Viable apoptotic cells have intact membrane which prevents EB from entering the interior of cells, possess yellow cytosol and condensed nuclei, with condensationlike or dead-like nuclear chromatin. Membrane of nonviable apoptotic cells is permeable, through which both AO and EB will enter, thus cells will display condensed nuclei and orange fluorescence (Figure 4 ).
Observation by transmission electron microscopy
The control group cell ( Figure 5A and C), cell plasma is homogenous and plump, cell nucleus is large and round, nucleoli is clear and regular, chromatin is Loose. Nucleus, nuclear membrane and sub-cellular structures are intact. There is a large number of microvilli on cell surface.
Cells in the experimental group ( Figure 5B and D), cell plasma format vacuoles, cell nucleus is Pyknosis, smaller, Nucleolus is shrink, concentrate or even disappear. Chromatin is aggregated, marginalized and is lumpish in the inner nuclear membrane and then heterochromatin is increase. Nuclear membrane is broken down and microvilli on cell surface are reduced. Mitochondria are a major resource and target of oxidative stress, and even play a central role in "the Free Radical Theory of Aging" (Alexeyev, 2009; Cadenas, and Davies 2000) .
MTT colorimetric assay
MTT assay showed that, for phloretin treated SMMC-7721 cells at 12 h, 24 h, 36 h, and 48 h, the viable cell population decreased significantly with elevated drug concentration and duration of treatment, appearing doseand duration-dependent (Figure 6 ). 
Annexin V-FITC/PI double-labeling
Quantitative analysis of apoptotic effects of phloretin on SMMC-7721 cells. Apoptotic rates increased with increasing duration and concentration (Figure 7 
Cell cycle progression
To test the mechanisms of phloretin induced SMMC-7721 cells apoptosis, cell cycle progression was analyzed by FCM. With the increasing concentration of phloretin, the percentage of cells increased in G1 phase, and decreased in S phase and G2 phase decreased, indicating an arrest in G1 phase, and that DNA synthesis was inhibited. The effects on cell cycle were even more significantly with elevated phloretin dose, reflecting a dose dependent correlation ( Figure 8B ). The percentage of apoptotic cells in hypodiploid DNA peak (sub-G1 population) was calculated by sub-G1 population / total cell cycle populations, and indicated by numbers shown in each histogram, sub-G1 population also showed doseand time-dependent (Figure 8 ).
Mitochondrial trans-membrane potential
To observe the changes in mitochondrial membrane potential after treatment by phloretin, cells were stained with JC-1 and examined by FCM. JC-1 is a lipophilic, cationic dye that can selectively enter mitochondria and reversibly change color from green to red as the membrane potential increases. JC-1 dye accumulates as aggregates in the mitochondria in normal cells, which results in red fluorescence, whereas, in apoptotic or necrotic cells, JC-1 exists in monomeric form and stains Figure 9A ). Mitochondrial trans-membrane potential significantly dropped after treatment with phloretin, displayed significant differences compared with the control ( Figure  9B ). Decreased mitochondrial transmembrane potential has been linked to apoptotic cell.
Intracellular calcium homeostasis
SMMC-7721 cells at 24 h after treatment with phloretin and were subsequently labelled with the molecular probe Fluo-3/AM. The results show that peak position in the histograms reflects the intracellular Ca 2+ concentration of phloretin treated SMMC-7721 cells ( Figure 10A ). The Ca 2+ concentration of experimental samples treated with phloretin of 20, 40, 80 and 160 mg/L displayed significant differences compared with the controls. It was revealed that there is a positive correlation between Ca 2+ release and phloretin concentration ( Figure 10B ).
DISCUSSION
Phloretin are polyphenols widely distributed in the plant kingdom, and they are present in fruits and vegetables regularly consumed by humans. Phloretin, a polyphenolic compound, have potent anti-inflammatory, anti-oxidative, and even some anticancer activities form the scientific basis for the common saying ""an apple a day keeps the doctor away."" Phloretin can inhibit tumor formation and induce apoptosis of tumor cells (So, 2006; Zhang, 2007) . One study showed that 200 µM Phloretin was used to induce HepG2 cell apoptosis (Brown and Attardi, 2005) , and phloretin at 30 µM protected peptide-induced plasma membrane damage in PC12 cells, while 300 µM Phloretin became toxic to the cells (Hertel et al., 1997) . Using primary rat hepatocytes, previous reports demonstrated that Phloretin at 0.4 to 200 µM significantly reduced tert-butyl hydroperoxide-induced cytotoxicity , and reported that the LD 50 of Phloretin is 500±51 µM (Moridani et al., 2002) . Our study evaluated a wide variety of apoptotic indices, and definitely proved that a certain concentration of phloretin can inhibit the proliferation of SMMC-7721 cells and induce apoptosis, and hence have huge anti-tumor effects.
Cell cycle progression
It is generally believed that physiological or pathological apoptotic stimuli are correlated with cell cycle progression (Siegers et al., 1999) . Unscheduled proliferation constitutes a key step in canceration, and an altered death to division speed would eventually lead to malignant transformation and neoplastic growth (Frantz et al., 2000) . Currently considered, cell cycle arrest would induce apoptosis, and influence proliferation. Many apoptotic signals affect apoptotic machineries as well as cell cycle progression at the same time. Therefore cell cycle analysis is one of the most important evaluations in apoptotic research. Furthermore, blocking cell cycle to induce apoptosis now serves as a new target for anticancer drugs. Structurally similar to glucose, phloretin has the molecular structure of 4-hydroxy and thus forms non-competitive inhibition with glucose transport, inhibit energy source and promote apoptosis.
One study shows that treatment of HepG2 cells with 100 and 150 µM phloretin for 24 h slightly increased the populations in G0/G1 and G2/M, respectively. In contrast, treatment of HepG2 cells with 200 µM phloretin for 24 h significantly induced HepG2 cell death, evidenced by an increase in the sub-G1 population (Chih-Hsiung et al., 2009) . By cell cycle analysis after Phloretin treatment, it was found that the cells were arrested in G1 phase with decreased proportion of S and G2 phases, causing a reduction in M phase and inhibited cell division. With elevated phloretin concentration, the proportion of cells in G1 phase, hypodiploid DNA (sub-G1 population) increased and that of cells in S phase decreased. Therefore, we speculate that with the aromatic ring structure phloretin can insert into the DNA double helix, thereby preventing DNA synthesis, affecting cell cycle progression and leading to apoptosis.
Treatment with 40 mg/L phloretin increased in G2 phase proportion, whereas 80 mg/L phloretin decreased in G2 phase proportion. This is possibly due to that 40 mg/L of phloretin mainly prevents cells entering G1 phase, and then S/G2 transition, therefore leading to a temporary increase in G2 phase. With increased phloretin concentration, 160 mg/L of phloretin caused the cells number of G2 phase to reduce. It is likely that phloretin plays a role in cell cycle progression and thus exerts it effects in apoptosis. This provides an important experimental basis for future mechanism study of phloretin induced apoptosis in hepatoma cells.
Mitochondrial trans-membrane potential
Apoptosis occurs through activation of a cell suicide process regulated by many different intracellular and extracellular events. It is generally accepted that caspases play an essential role in the induction and execution of apoptosis. There are two distinct pathways leading to caspase activation and ensuing apoptosis, the death receptor pathway and the mitochondrial pathway. In the apoptotic process, many important events including are closely related with mitochondrion (Bouchier-Hayes et al., 2005) , which is that mitochondrial trans-membrane potential drops (Amstrong, 2006) , membrane permeability increases, mitochondrial permeability transition pore opens (Disa, and Bailly 2005; LuckenArdjomande, 2005) , and then mitochondria of cytochrome C (Mohamad et al., 2005) , apoptosis inducing factor (AIF) Wang et al. 657 (Liu et al., 1997) , etc. enter the cytoplasm, starting the process of apoptosis. In the mitochondrial pathway, the release of cytochrome c from mitochondria is a crucial step in the activation of caspases. Once released to the cytosol, cytochrome c associates with apoptosis proteinactivating factor-1 (Apaf-1), forming an apoptosome complex that, in the presence of ATP or dATP, is capable of activating procaspase-9. Initiator caspases, activated through either one of these two pathways, can in turn activate caspase-3 and other effector caspases responsible for dismantling of the dying cell. Therefore, biochemical and morphological changes, including cellular shrinkage, chromatin condensation and DNA fragmentation, are almost invariably involved in both pathways (Johansson et al., 2003) . The drop of mitochondrial trans-membrane potential is considered to be the first event of apoptotic signaling, which occurs before occurrence of apoptotic characteristics in nuclear. The present study of apoptotic mechanism shows that mitochondrion plays a pivotal role in the process of apoptosis. Mitochondrial transmembrane potential will change when apoptosis happens, leading to changes in membrane permeability. Mitochondrial membrane potential, the driving force of ATP production, is decreased during apoptosis (Richter et al., 1996) . ATP depletion is an important mechanism of apoptosis (Moley, 2005; Nakamura, and Wada 2000) .
Phloretin is an uncoupler, which can inhibit mitochondrial oxidative phosphorylation (Jonge et al., 1983) , block ATP synthesis, decrease energy generation, and hence induce apoptosis. In this study, cells labeled with JC-1 staining solution were subjected to flow cytometry detect changes in mitochondrial transmembrane potential. It was found mitochondrial transmembrane potential decrease in SMMC-7721 cells upon treatment with phloretin, subsequently by the possible suppression of ATP production even lead to ATP depletion and breakdown of mitochondria, activating downstream apoptotic pathways, therefore, suggesting that phloretin induced apoptosis of SMMC-7721 cells is related to mitochondrial pathway.
Intracellular calcium homeostasis
In normal cells, Ca 2+ mainly combined with protein cistern in endoplasmic reticulum and mitochondrion. There is little dissociative Ca 2+ , unless the receipt of external stimuli trigger its release as molecule messenger. Almost all cell responses, including contraction, exocytosis, gene expression and apoptosis, are controlled by partial or total change dissociative Ca 2+ concentration. Research has shown that the excessive accumulation of intracellular free Ca 2+ can lead to the occurrence of apoptosis (Jiang et al., 1994) .
The release of Ca 2+ from the endoplasmic reticulum into the cytoplasm has been implicated as a key-signaling event in many models of apoptosis and it may sensitize mitochondria to trigger apoptotic cell death. In addition, an increasing number of endoplasmic reticulum proteins have been described to influence apoptosis by either interacting with Bcl-2 family members or altering endoplasmic reticulum Ca 2+ responses. Also, several endoplasmic reticulum proteins are caspase substrates that may regulate the execution phase of apoptosis (Breckenridge, 2003) .
Generally, in response to endoplasmic reticulum stress, Bax and Bak undergo conformational changes to cause the release of Ca 2+ from endoplasmic reticulum lumen into cytoplasm, followed by the activation of calpain. Upon exposure to Ca 2+ , calpain subunits undergo autocleavage, which facilitates activation and ultimately leads to calpain degradation (Goll, 2003) . Beside the participation in apoptosis by cleaving either pro-apoptotic and anti-apoptotic proteins based on the nature of stimuli and type of cells involved , calpain has been reported to cleave caspase-4 that is supposed to function in endoplasmic reticulum stress-mediated apoptosis (Hitomi, 2004) .
Mitochondrion is an intracellular calcium store. The Ca 2+ uptake depends on mitochondrial trans-membrane potential. Mitochondrial Ca 2+ elevation mechanisms include non-specific leakage and pore formation. With the existence of proper stimulus, Ca 2+ is released from mitochondrion and endoplasmic reticulum. Mitochondrial calcium overload leads to mitochondrial damage, release of cytochrome C and caspase activation, and subsequent apoptosis.
Phloretin can exert significant effect on Ca 2+ current (Olson et al., 2007) . Our data demonstrated when phloretin induced apoptosis of SMMC-7721 cells, cytosolic free Ca 2+ concentration increased, so that Ca 2+ homeostasis was disturbed. It indicates appropriate concentration of phloretin has significant effects in inducing apoptosis on SMMC-7721 cells. The result of disturbed calcium homeostasis, taken together with mitochondrial trans-membrane potential decrease, presumably links it with endoplasmic reticulum calcium release.
In conclusion, our results show that phloretin induces apoptosis in hepatoma cells by inhibiting DNA synthesis, reducing mitochondrial membrane potential and interferencing calcium homeostasis. These findings may have potential applications in the treatment of liver cancer. The results demonstrate that phloretin might be developed into a new anti-cancer drug.
